Back to Search
Start Over
Brentuximab vedotin in refractory or relapsed peripheral T-cell lymphomas: the French named patient program experience in 56 patients.
- Source :
-
Haematologica [Haematologica] 2016 Mar; Vol. 101 (3), pp. e103-6. Date of Electronic Publication: 2015 Dec 24. - Publication Year :
- 2016
- Subjects :
- Adult
Aged
Aged, 80 and over
Brentuximab Vedotin
Drug Administration Schedule
Drug Dosage Calculations
Female
France
Humans
Ki-1 Antigen metabolism
Lymphoma, T-Cell, Peripheral mortality
Lymphoma, T-Cell, Peripheral pathology
Male
Middle Aged
Pilot Projects
Prognosis
Recurrence
Retrospective Studies
Signal Transduction
Survival Analysis
Antineoplastic Agents therapeutic use
Gene Expression Regulation, Neoplastic
Immunoconjugates therapeutic use
Ki-1 Antigen genetics
Lymphoma, T-Cell, Peripheral drug therapy
Lymphoma, T-Cell, Peripheral genetics
Subjects
Details
- Language :
- English
- ISSN :
- 1592-8721
- Volume :
- 101
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Haematologica
- Publication Type :
- Report
- Accession number :
- 26703966
- Full Text :
- https://doi.org/10.3324/haematol.2015.135400